NCT03863821 is a NA clinical trial of HHHFNC in COPD, sponsored by Fu Jen Catholic University.

Who is sponsoring NCT03863821?

NCT03863821 is sponsored by Fu Jen Catholic University.

What drugs are being tested in NCT03863821?

Interventions in NCT03863821: HHHFNC.

What condition does NCT03863821 study?

NCT03863821 studies COPD, Pulmonary Disease, Rehabilitation.

Is NCT03863821 still recruiting?

NCT03863821 is currently completed. Last updated 30 December 2019.

Last reviewed 2019-12-30 · How we verify

NCT03863821

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Application and Analysis of HHHFNC in Walking Test of Pulmonary Rehabilitation

Completed NA Last updated 30 December 2019

What this trial tests

NA trial testing HHHFNC in COPD in 30 participants. Completed in 30 November 2019.

Timeline

18 March 2019

Primary endpoint
30 November 2019

30 November 2019

Quick facts

Lead sponsor	Fu Jen Catholic University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	18 March 2019
Primary completion	30 November 2019
Estimated completion	30 November 2019
Sites	1 location across Taiwan

Drugs / interventions tested

HHHFNC

Conditions studied

COPD — all drugs for COPD →
Pulmonary Disease — all drugs for Pulmonary Disease →
Rehabilitation — all drugs for Rehabilitation →

Sponsor

Fu Jen Catholic University

Who can join

18 and older, any sex, with COPD or Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the use heated humidified high-flow nasal cannula (HHHFNC) in pulmonary rehabilitation and analysis of cardiopulmonary parameters in adult patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of high-flow nasal cannula with oxygen on self-paced exercise performance in COPD: A randomized cross-over trial.
Chao KY, Liu WL, Nassef Y, Tseng CW, et al · · 2021 · cited 8× · PMID 34941043 · DOI 10.1097/md.0000000000028032

Verify or expand the search:

Other trials of HHHFNC

Trials testing the same drug.

NCT04282369 — Evaluation Of The Efficacy Of Four Different Non-invasive Ventilation Modes Performed In The Delivery Room · NA · unknown
NCT03548324 — Enteral Nutrition Tolerance And REspiratory Support (ENTARES) · NA · completed
NCT03811158 — The Edi Level and Cardiopulmonary Function Between HHHFNC and Unheated Humidified High-Flow Oxygen Mask in COPD · NA · terminated

Other recruiting trials for COPD

Currently open trials in the same condition.

NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting

Other Fu Jen Catholic University trials

Trials by the same sponsor.

NCT07474220 — Expression of SLC25A48 in Chronic Obstructive Pulmonary Disease · not yet recruiting
NCT07445035 — Effects of Mobilization Using a Powered Lower-limb Exoskeleton With Prolonged Mechanical Ventilation · NA · not yet recruiting
NCT07497932 — Nutritional Effects in Cardiovascular Surgery · NA · recruiting
NCT07482800 — Dementia in Fiction and Clinical Narratives · recruiting
NCT07447232 — Comparing Ultrasonic and Conventional Spirometry in Chronic Respiratory Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03863821 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fu Jen Catholic University
Last refreshed: 30 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03863821.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing